Skip to content

Clinical trials

Phase 2 Hemoglobinopathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinopathies Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20041
20081
20092
20141
20171
20202
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baylor College of Medicine2
Fred Hutchinson Cancer Center2
Children's Hospital of Philadelphia1
Craig Seaman1
Dana-Farber Cancer Institute1
Forma Therapeutics, Inc.1
Johns Hopkins All Children's Hospital1
Masonic Cancer Center, University of Minnesota1
Memorial Sloan Kettering Cancer Center1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinopathies15
Anemia, Sickle Cell9
Thalassemia6
Bone Marrow Failure Disorders5
beta-Thalassemia3
Anemia, Hemolytic2
Hemoglobin SC Disease2
Immunologic Deficiency Syndromes2
Leukemia, Myeloid, Acute2
Lymphohistiocytosis, Hemophagocytic2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.